Bio

Alex Geier joined GLC in 2020 and leads the firm’s Healthcare practice. He has more than 25 years of overall experience across Services, Digital Health/HCIT, Medical Devices and Life Sciences, as well as deep subject matter expertise in the public and private credit markets. Representative transactions at GLC include Carestream Health, Healogics, Invacare, SpineOne and StimWave Technologies. Mr. Geier was most recently with BMO Financial Group, where he ran the Healthcare Sponsor Finance team for 6 years, and also served as a Managing Director covering Healthcare in the Leveraged Finance Group of BMO Capital Markets. Prior to joining BMO, Mr. Geier spent 12 years at UBS in Healthcare-focused roles in Leveraged Finance, Capital Markets and High Yield Research. He previously covered the sector as a High Yield Analyst at BT Alex.Brown and Bank of America. Overall, Mr. Geier has worked on more than 200 Healthcare assignments, encompassing a wide range of transaction types (restructurings, mergers and acquisitions, leveraged buyouts, carve-outs, dividend and other recapitalizations, exit financings, refinancings and growth capital) and financing instruments (1st and 2nd-lien loans, high yield bonds and bridge loans, unitranche facilities, mezzanine debt and preferred and common equity). Mr. Geier holds FINRA Series 24, 50, 63 and 79 licenses as well as an MBA from the Kellogg School at Northwestern University and an AB in Political Science and Economics from Duke University.